Patients Discontinuing Slimming Medications Gain Back Weight at a Quadrupled Rate Than Dieters

A recent study suggests that people who stop using popular GLP-1 drugs like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who end traditional diet and exercise plans.

Findings released in a major health publication shows that while obese individuals frequently drop substantial amounts of their body weight while using the jabs, the mass returns at an average rate of nearly a kilo each month once they quit.

"Individuals purchasing these drugs need to be aware of the potential of rapid weight regain when the treatment is stopped," warns lead investigator Dr. Susan Jebb.

That rate of regain implies a return to original mass within about a year and a half.

Weighing Therapies

The analysis, which examined dozens of studies involving thousands of participants, contrasted the outcomes of these new drugs with older methods.

Researchers emphasize that people who lose weight through diet and exercise typically have a slower weight regain—perhaps 100 grams monthly—after stopping.

Understanding the Rapid Rebound

Doctors believe the way of the drugs explains the amplified regain.

GLP-1 drugs copy a natural hormone called GLP-1, which controls feelings of fullness.

"Artificially providing GLP-1 levels far above than normal might result in the system to produce less of its own natural GLP-1, and could lessen sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this hormone supplement means hunger is unsuppressed, making excessive eating a significant risk."

A Lifelong Issue?

The NHS recommend the injections for individuals with obesity-related health risks, alongside prescribed lifestyle changes.

A number of clinicians contend that, given the significant potential of relapse, the treatment should be considered ongoing.

This opinion is echoed by drug manufacturers, who state that the results "underscore the chronic nature of obesity," similar to managing conditions like hypertension.

User Accounts

Users who have discontinued the medication explain a sudden return of hunger.

"It felt as if something activating and you become ravenous," said an individual.

This challenge is compounded if users have not established permanent lifestyle or habit changes during treatment.

Growing Use

Figures indicate that millions of people in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.

• Use is higher among females compared to males.
• The 40s and 50s age group shows the greatest level of interest.
• A large proportion access the medications through private prescriptions rather than the NHS.

In conclusion, clinicians caution that while these medications are effective tools for weight loss, they are not a permanent solution and lasting health benefits likely depends on integrated lifestyle management.